Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6YYQ

Structure of Cathepsin S in complex with Compound 3

This is a non-PDB format compatible entry.
Summary for 6YYQ
Entry DOI10.2210/pdb6yyq/pdb
DescriptorCathepsin S, (6~{R})-2-phenyl-5,6,7,8-tetrahydroquinazolin-6-amine (3 entities in total)
Functional Keywordscathepsin s, inhibitor, hydrolase
Biological sourceHomo sapiens (Human)
Total number of polymer chains4
Total formula weight101100.55
Authors
Wagener, M.,Schade, M.,Merla, B.,Hars, U.,Kueckelhaus, S.Q. (deposition date: 2020-05-05, release date: 2021-05-12, Last modification date: 2024-10-16)
Primary citationSchade, M.,Merla, B.,Lesch, B.,Wagener, M.,Timmermanns, S.,Pletinckx, K.,Hertrampf, T.
Highly Selective Sub-Nanomolar Cathepsin S Inhibitors by Merging Fragment Binders with Nitrile Inhibitors.
J.Med.Chem., 63:11801-11808, 2020
Cited by
PubMed Abstract: Pharmacological inhibition of cathepsin S (CatS) allows for a specific modulation of the adaptive immune system and many major diseases. Here, we used NMR fragment screening and crystal structure-aided merging to synthesize novel, highly selective CatS inhibitors with picomolar enzymatic Ki values and nanomolar functional activity in human Raji cells. Noncovalent fragment hits revealed binding hotspots, while the covalent inhibitor structure-activity relationship enabled efficient potency optimization.
PubMed: 32880457
DOI: 10.1021/acs.jmedchem.0c00949
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.51 Å)
Structure validation

236963

PDB entries from 2025-06-04

PDB statisticsPDBj update infoContact PDBjnumon